Transparency Market Research Report Added “Regenerative Medicine Market (Bone and
Joint) (Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; Application Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others)" to its database.
Global Regenerative Medicine Market: Snapshot Increasing application areas such as neurology, cardiovascular, musculoskeletal and orthopedic diseases will build up greater opportunities, states TMR. The market for regenerative medicine market appears to be fragmented in terms of competition. The Asia Pacific region will present large opportunities, displaying a promising CAGR between 2013 and 2019. The Asian countries such as South Korea, China, and Japan hold considerable prospects for augmentation of global regenerative medicine market. Smith & Nephew, a British medical equipment manufacturing company acquired Sushrut Surgical Pvt. Ltd., an India-based medical technology firm, enhancing access to the consumer pool in Asian countries in order to secure larger profits. The global regenerative medicine market was pegged at US$2.5 mn in 2012. It is projected to achieve US$6.4 mn by the end of 2019, expanding at a progressive CAGR of 12.8% during the forecast period. Browse Market Research Report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html
North America Leads Due to Increasing Bone and Joint Reconstructive Surgeries North America, owing to a large number of leading companies operating in regenerative medicine, dominates the global regenerative medicine market. The ongoing expansive research and development activities in the U.S. will also drive the North America segment. The bone and joint regenerative medicine market is the leading application segment in this region, as a high demand for regenerative medicine is exhibited. The region of Asia Pacific will witness monumental growth because of its massive consumer pool, rising disposable incomes of people, and growing healthcare expenditure. Over the coming years, the regenerative medicine market in Asia Pacific will benefit from the growing demand for orthopedic surgeries, technological innovations, high incidence of joint and bone diseases, and increasing awareness
about regenerative medicine. However, the market might face challenges such as high costs and regulatory policies. Japan displays great potential on account several favorable factors. Fewer regulatory restraints, coupled with technological advancements in the area of regenerative medicine will ensure market expansion in the country. One key technological development is the emergence of 3D tissue bioprinters that enable the creation of blood vessels, cartilage, skin and other tissues. Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=419
Table of Contents Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Assumptions 1.4 List of Abbreviations Chapter 2 Executive Summary 2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %) Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers
3.2.1 Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products 3.2.2 Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products 3.2.3 Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market 3.3 Restraints 3.3.1 Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market 3.3.2 Ethical issues and post implantation infections are hindering overall market growth 3.4 Opportunities 3.4.1 Capitalization on the potential presented by emerging markets in Asia Pacific 3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market 3.5.1 Bargaining power of suppliers 3.5.2 Bargaining power of buyers 3.5.3 Threat of new entrants 3.5.4 Threat of substitutes 3.5.5 Competitive rivalry 3.6 Competitive Landscape 3.6.1 Market Share Analysis by Key Players, 2012 (Value %) 3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology 4.1 Introduction
4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 4.2 Stem Cell Therapy 4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 4.3 Biomaterials 4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 4.4 Tissue Engineering 4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications 5.1 Overview 5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 5.2 Bone Graft Substitutes 5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 5.3 Osteoarticular Diseases 5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 5.4 Allogeneic Bones 5.4.1 Global Allogenic Bones Application Market Revenue, 2011 – 2019 (USD Million) 5.5 Autogenic Bones 5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 5.6 Others 5.6.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography 6.1 Overview 6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 6.2 North America 6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 6.3 Europe 6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 6.5 Rest of the World (RoW) 6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) Chapter 7 Recommendations 7.1 Market Strategy for Success 7.1.1 Rigorous research and development initiatives for innovative products 7.1.2 Investing in emerging economies 7.2 Barriers and Future Assumptions 7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth Chapter 8 Company Profiles 8.1 Anika Therapeutics, Inc. 8.1.1 Company Overview
8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Arthrex, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Baxter International, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 CONMED Corporation 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies
8.4.5 Recent Developments 8.5 DePuy Synthes, Inc. 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Medtronic, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Smith & Nephew plc 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Stryker Corporation 8.8.1 Company Overview
8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Zimmer Holdings, Inc. 8.9.1 Business Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments List of Figures FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %) FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %) FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%) FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (USD Million) FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (USD Million) FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (USD Million) FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million) FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (USD Million) FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (USD Million) List of Tables TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019)
TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) TABLE 5 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) About Us Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement. Contact Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Browse market research blog: https://tmrresearch.blogspot.com/